Posttranslational modifications (PTMs) of proteins by phosphorylation are a well-established mechanism by which their activities can be regulated to affect cellular physiology. However, it is becoming increasingly evident that PTMs of proteins by acetylation of lysine residues is also a key effecter in regulating their functional abilities. The best characterized case of this is the epigenetic effects of histone acetyltransferases and deacetylases on gene expression via modulation of nuclear histone acetylation and chromatin remodeling. However, recent published evidence now strongly implicates an important role for nonhistone acetylation in regulating cellular function. In this review, we have considered the potential for regulating myometrial activity not only by epigenetic mechanisms but also by nonepigenetic protein acetylation processes that could directly affect the contractile machinery within these smooth muscle cells.
Lopez BernalAWatsonSPPhaneufSEurope-FinnerGN. Biochemistry and physiology of preterm labour and delivery. Baillieres Clin Obstet Gynaecol. 1993;7(3):523–552.
2.
ChardT. Fetal and maternal oxytocin in human parturition. Am J Perinatol. 1989;6(2):145–152.
3.
ChallisJRLyeSJGibbW. Prostaglandins and parturition. Ann N Y Acad Sci. 1997;828:254–267.
4.
MackenzieLWWordRACaseyMLStullJT. Myosin light chain phosphorylation in human myometrial smooth muscle cells. Am J Physiol. 1990;258(1 pt 1):C92–C98.
5.
SlatteryMMBrennanCO'LearyMJMorrisonJJ. Human chorionic gonadotrophin inhibition of pregnant human myometrial contractility. BJOG. 2001;108(7):704–708.
6.
DongYLFangLKondapakaSGangulaPRWimalawansaSJYallampalliC. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest. 1999;104(5):559–565.
7.
MeeraPAnwerKMongaM. Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol. 1995;269(2 pt 1):C312–C317.
8.
TanseyMGWordRAHidakaH. Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells. J Biol Chem. 1992;267(18):12511–12516.
9.
BoroditskyRSReyesFIWinterJSFaimanC. Maternal serum estrogen and progesterone concentrations preceding normal labour. Obstet Gynecol. 1978;51(6):686–691.
10.
MesianoSChanECFitterJTKwekKYeoGSmithR. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002;87(6):2924–30.
11.
DekkerFJHaismaHJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today2009;14(19-20):942–948.
12.
deRuijterAJvan GennipAHCaronHNKempSvan KuilenburgAB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370(pt 3):737–749.
13.
McLaughlinFLa ThangueNB. Histone deacetylase inhibitors open new doors in cancer therapy. Biochem Pharmacol. 2004;68(6):1139–1144.
14.
GuninAGKapitovaINSuslonovaNV. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus. J Endocrinol. 2005;185(3):539–549.
15.
CondonJCJeyasuriaPFaustJMWilsonJWMendelsonCR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci U S A. 2003;100(16):9518–9523.
16.
PhielCJZhangFHuangEYGuentherMGLazarMAKleinPS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J BiolChem2001;276(39):36734–36741.
17.
KultimaKNystromAMScholzBGustafsonALDenckerLStigsonM. Valproic acid teratogenicity: a toxicogenomics approach. Environ Health Perspect. 2004;112(12):1225–1235.
18.
PhillipsRJTyson-Capper Née Pollard AJBaileyJRobsonSCEurope-FinnerGN. Regulation of expression of the chorionic gonadotropin/luteinising hormone (CG/LH) receptor gene in the human myometrium: involvement of Sp1, Sp3, Sp4, Sp-like proteins and histone deacetylases (HDACs). J Clin Endocrinol Metabol. 2005;90(6):3479–3490.
19.
Karolczak-BayattiMLoughneyADRobsonSCEurope-FinnerGN. Epigenetic modulation of the protein kinase A RIIα (PRKAR2A) gene by histone deacetylase 1 & 2 in human smooth muscle cells. J Cell Mol Med. 2011;15(1):94–108. doi:10.1111/j.1582-4934.2009.00927.
20.
LindströmTMMohanARJohnsonMRBennettPR. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells. Mol Pharmacol. 2008;74(1):109–121.
21.
MoynihanATHehirMPSharkeyAMRobsonSCEurope-FinnerGNMorrisonJJ. Histone deacetylase inhibitors and a functional potent inhibitory effect on human uterine contractility. Am J Obstet Gynecol. 2008;199(2):167.e1–e7.
22.
ChenLFischleWVerdinEGreeneWC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science. 2001;293(5535):1653–1657.
23.
LangleyEPearsonMFarettaM. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 2002;21(10):2383–2396.
24.
KimSCSprungRChenY. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell. 2006;23(4):607–618.
25.
ChoudharyCKumarCGnadF. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834–840.
26.
OlsenJVBlagoevBGnadF. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127(3):635–648.
27.
GnadFRenSCoxJ. PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphor-sites. Genome Biol. 2007; 8(11):R250.
28.
MalikRNiggEAKörnerR. Comparative conservation analysis of the human mitotic phosphoproteome. Bioinformatics. 2008;24(12):1426–1432.
29.
HubbertCGuardiolaAShaoR. HDAC6 is a microtubule-associated deacetylase. Nature2002,417(6887):455–458.
30.
BuggyJJSiderisMLMakPLorimerDDMcIntoshBClarkJM. Cloning and characterization of a novel human histone deacetylase HDAC8. Biochem J. 2000;350(pt 1):199–205.
31.
ChenSOwensGCMakarenkovaHEdelmanDB. HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS ONE2010;5(5):e10848. doi:10.1371/journal.pone.0010848.
32.
GuptaMPSamantSSmithSHShroffSG. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating the myofilament contractile activity. J Biol Chem. 2008;283(15):10135–10146.
33.
HuEChenZFredricksonT. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem. 2000;275(20):15254–15264.
34.
WaltregnyDDe LevalLGlenissonW. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am J Pathol. 2004;165(2):553–564.
35.
WaltregnyDGlenissonWTranSL. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 2005;19(8):966–968.
36.
LeeHRezai-ZadehNSetoE. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol. 2004;24(2):765–773.
37.
Karolczak-BayattiMTaggartMJRobsonSCUlrichSMEurope-FinnerGN. Evaluation of linkerlesshydroxamic acid derivatives as selective HDAC8 inhibitors in regulating myometrial contractility. Reprod Sci. 2010;17:53.
38.
KrennhrubecKMarshallBLHedglinMVerdinEUlrichSM. Design and evaluation of ‘Linkerless' hydroxamic acids as selective HDAC8 inhibitors. Bioorg Med Chem Lett. 2007;17(10):2874–2878.
